Intravenous Thrombolysis for Acute Stroke
Neurol 49:14-29, Lyden,P.D.,et al, 1997
Systematic Review of Evidence on Thrombolytic Therapy for Acute Ischaemic Stroke
Lancet 350:607-614, Wardlaw,J.M.,et al, 1997
A Systems Approach to Immediate Evaluation and Management of Hyperacute Stroke
NINDS Stroke Study Group, Stroke 28:1530-15401997., , 1997
CAST:Random Placebo-Controlled Trial of Early Aspirin Use in 20000 Pts with Acute Ischaemic Stroke
CAST Collab Grp, Lancet 349:1641-16491997., , 1997
Intl Stroke Trial:Random Trial of ASA
Subcut Heparin, Both, or Neither Among 19435 Pts with Ischaemic Stroke, IST Collab Grp, Lancet 349:1, 69-11997., 1997
Carotid Occlusive Disease and Stroke Risk in Coronary Artery Bypass Graft Surgery
Neurol 49:678-686, Dashe,J.F.,et al, 1997
Severe Pathological Crying After Left Anterior Choroidal Artery Infarct
Stroke 28:1464-1466, Derex,L.,et al, 1997
The Risks and Benefits of Carotid Endarterectomy in Patients with Near Occlusion of the Carotid Artery
Neurol 48:911-915, Morgenstern,L.B.,et al, 1997
Stroke Patients'Knowledge of Stroke
Stroke 28:912-915, Williams,L.S.,et al, 1997
Percutaneous Transluminal Angioplasty for Total Occlusion of Middle Cerebral Arteries
Neuroradiology 39:71-74, Mori,T.,et al, 1997
Primary Care Physician-Reported Secondary and Tertiary Stroke Prevention Practices
Stroke 28:746-751, Goldstein,L.B.,et al, 1997
Treatment of Multiple Cerebral Emboli from an Ulcerated, Thrombogenic Ascending Aorta with Aortectomy and Graft Replacement
Neurol 49:621-622, Belden,J.R.,et al, 1997
Stenting for Carotid Stenosis? [Letter]
NEJM 337:427-428, , 1997
Characterizing the Target of Acute Stroke Therapy
Stroke 28:866-872, Fisher,M., 1997
Prognosis of Stroke Patients Requiring Mechanical Ventilation in a Neurological Critical Care Unit
Stroke 28:711-715, Steiner,T.,et al, 1997
Inflammation, Aspirin, and the Risk of Cardiovascular Disease in Apparently Healthy Men
NEJM 336:973-979, 1014-10161997., Ridker,P.M.,et al, 1997
Management of Anticoagulation Before and AFter Elective Surgery
NEJM 336:1506-1511, Kearon,C.&Hirsh,J., 1997
Influence of Cholesterol on Survival After Stroke:Retrospective Study
BMJ 314:1584-1588, Dyker,A.G.,et al, 1997
Amelioration of Refractory Dysesthetic Limb Pain in Multiple Sclerosis by Gabapentin
Neurol 49:304-305, Samkoff,L.M.,et al, 1997
Interferon Beta Results in Immediate Reduction of Contrast-Enhanced MRI Lesions in MS Pts Followed by Weekly MRI
Neurol 48:1446-1448, Calabresi,P.A.,et al, 1997
Character of MRI Response to Trtm with Interferon Beta-1B:Enhancing MRI Lesion Freq as Prim Outcome Measure
Neurol 49:862-869, Stone,L.A.,et al, 1997
Impact of Interferon Beta-1A On Neurologic Disability in Relapsing Multiple Sclerosis
Neurol 49:358-363, Rudick,R.A.,et al, 1997
Quantitative Assessment of Sustained-Release 4-Aminopyridine for Symptomatic Treatment of Multiple Sclerosis
Neurol 48:817-821, Schwid,S.R.,et al, 1997
Glatiramer Acetate for Relapsing Multiple Sclerosis
The Medical Letter 39:61-62, , 1997
Randomised Trial of Oral and Intravenous Methylprednisolone in Acute Relapses of Multiple Sclerosis
Lancet 349:902-906, 8931997., Barnes,D.,et al, 1997
Human Response to Botulinum Toxin Injection:Type B Compared with Type A
Neurol 49:189-194, Sloop,R.R.,et al, 1997
Posteroventral Pallidotomy in a Patient with Parkinsonism Caused by Hypoxic Encephalopathy
Neurol 49:707-710, Goto,S.,et al, 1997
Olanzapine:A Novel Atypical Neuroleptic Agent
Lancet 349:1264-1265, Reus,V.I., 1997
Safety and Efficacy of Pramipexole in Early Parkinson Disease
Parkinson Study Group, JAMA 278:125-1301997., , 1997
Clinical Evaluation of Pramipexole in Advanced Parkinson's Disease
Neurol 49:162-168, Lieberman,A.,et al, 1997
Efficacy of Pramipexole, A Novel Dopamine Agonist, As Monotherapy in Mild to Moderate Parkinson's Disease
Neurol 49:724-728, Shannon,K.M.,et al, 1997
Pharmacologic Profile of Ropinirole:A Nonergoline Dopamine Agonist
Neurol 49:558-562, Tulloch,I.F., 1997
Ropinirole for the Treatment of Early Parkinson's Disease
Neurol 49:393-399, Adler,C.H.,et al, 1997
Managing the Late Complications of Parkinson's Disease
Neurol 49:549-557, Waters,C.H., 1997
Tolcapone in Stable Parkinson's Disease:Efficacy and Safety of Long-Term Treatment
Neurol 49:665-671, Waters,C.H.,et al, 1997
Gabapentin for Idiopathic Trigeminal Neuralgia:Report of Two Cases
Neurol 48:1467, Sist,T.,et al, 1997
Clinical Effectiveness of Lamotrigine and Plasma Levels in Essential and Symptomatic Trigeminal Neuralgia
Neurol 48:1714-1717, Lunardi,G.,et al, 1997
Risk Factors for Postherpetic Neuralgia
Arch Int Med 157:1217-1224, 11661997., Choo,P.W.,et al, 1997
The Effect of Treating Herpes Zoster with Oral Acyclovir in Preventing Postherpetic Neuralgia
Arch Int Med 157:909-912, Jackson,J.L.,et al, 1997
Donepezil (Aricept) for Alzheimer's Disease
The Medical Letter 39:53-54, , 1997
A Controlled Trial of Selegiline, Alpha-Tocopherol, or Both as Treatment for Alzheimer's Disease
NEJM 336:1216-1222, 12451997., Sano,M.,et al, 1997
Clinical Features and Pharmacologic Treatment of Behavioral Symptoms of Alzheimer's Disease
Neurol 48 (Suppl 6) :S17-S24997., Borson,S.&Raskind,M.A., 1997
Cognitive Function and The costs of Alzheimer Disease
Arch Neurol 54:687-683, Ernst,R.L.,et al, 1997
Tiagabine Therapy for Complex Partial Seizures
Arch Neurol 54:959-601, Sachdeo,R.C.,et al, 1997
Persistent Vegetative State
Lancet 350:795-799, Zeman,A., 1997
Three Hundred Sixty-Degree Rotation of the Posterior Semicircular Canal for Trtm of Benign Positional Vertigo
Neurol 49:729-733, Lempert,T.,et al, 1997
A 44-Month Clinical-Brain MRI Follow-Up in a Patient with B12 Deficiency
Neurol 49:878-881, Stojsavljevic,N.,et al, 1997
Improvement of Stiff-Man Syndrome with Vigabatrin
Neurol 48:1133-1134, Prevett,M.C.,et al, 1997
Central Poststroke Pain & Wallenberg's Lateral Medullary Infarction:Freq, Charact & Determinants in 63 Pts
Neurol 49:120-125, MacGowan,D.J.L.,et al, 1997
Peripheral Neuropathy Associated with Sicca Complex
Neurol 48:855-862, Grant,I.A.,et al, 1997